156 related articles for article (PubMed ID: 26733813)
41. Virus demyelination.
Fazakerley JK; Walker R
J Neurovirol; 2003 Apr; 9(2):148-64. PubMed ID: 12707846
[TBL] [Abstract][Full Text] [Related]
42. Murine hepatitis virus--a model for virus-induced CNS demyelination.
Matthews AE; Weiss SR; Paterson Y
J Neurovirol; 2002 Apr; 8(2):76-85. PubMed ID: 11935460
[TBL] [Abstract][Full Text] [Related]
43. The potential for oligodendrocyte proliferation during demyelinating disease.
Prayoonwiwat N; Rodriguez M
J Neuropathol Exp Neurol; 1993 Jan; 52(1):55-63. PubMed ID: 8381162
[TBL] [Abstract][Full Text] [Related]
44. Morphology of oligodendrocytes during demyelination in optic nerves of mice infected with Semliki Forest virus.
Butt AM; Tutton MG; Kirvell SL; Amor S; Jenkins HG
Neuropathol Appl Neurobiol; 1996 Dec; 22(6):540-7. PubMed ID: 9004245
[TBL] [Abstract][Full Text] [Related]
45. Chimeric Theiler's virus with altered tropism for the central nervous system.
Jarousse N; Fiette L; Grant RA; Hogle JM; McAllister A; Michiels T; Aubert C; Tangy F; Brahic M; Peña Rossi C
J Virol; 1994 May; 68(5):2781-6. PubMed ID: 8151749
[TBL] [Abstract][Full Text] [Related]
46. Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury.
Marignier R; Nicolle A; Watrin C; Touret M; Cavagna S; Varrin-Doyer M; Cavillon G; Rogemond V; Confavreux C; Honnorat J; Giraudon P
Brain; 2010 Sep; 133(9):2578-91. PubMed ID: 20688809
[TBL] [Abstract][Full Text] [Related]
47. Expression of hemagglutinin esterase protein from recombinant mouse hepatitis virus enhances neurovirulence.
Kazi L; Lissenberg A; Watson R; de Groot RJ; Weiss SR
J Virol; 2005 Dec; 79(24):15064-73. PubMed ID: 16306577
[TBL] [Abstract][Full Text] [Related]
48. Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination.
Wang FI; Hinton DR; Gilmore W; Trousdale MD; Fleming JO
Lab Invest; 1992 Jun; 66(6):744-54. PubMed ID: 1318460
[TBL] [Abstract][Full Text] [Related]
49. Effect of persistent mouse hepatitis virus infection on MHC class I expression in murine astrocytes.
Correale J; Li S; Weiner LP; Gilmore W
J Neurosci Res; 1995 Jan; 40(1):10-21. PubMed ID: 7714917
[TBL] [Abstract][Full Text] [Related]
50. Mouse hepatitis virus A59-induced demyelination can occur in the absence of CD8+ T cells.
Gombold JL; Sutherland RM; Lavi E; Paterson Y; Weiss SR
Microb Pathog; 1995 Mar; 18(3):211-21. PubMed ID: 7565015
[TBL] [Abstract][Full Text] [Related]
51. Inside-Out versus Outside-In models for virus induced demyelination: axonal damage triggering demyelination.
Tsunoda I; Fujinami RS
Springer Semin Immunopathol; 2002; 24(2):105-25. PubMed ID: 12503060
[TBL] [Abstract][Full Text] [Related]
52. The pathologic role for COX-2 in apoptotic oligodendrocytes in virus induced demyelinating disease: implications for multiple sclerosis.
Carlson NG; Hill KE; Tsunoda I; Fujinami RS; Rose JW
J Neuroimmunol; 2006 May; 174(1-2):21-31. PubMed ID: 16516308
[TBL] [Abstract][Full Text] [Related]
53. Viral induced demyelination.
Stohlman SA; Hinton DR
Brain Pathol; 2001 Jan; 11(1):92-106. PubMed ID: 11145206
[TBL] [Abstract][Full Text] [Related]
54. Mouse hepatitis virus strain JHM infects a human hepatocellular carcinoma cell line.
Koetters PJ; Hassanieh L; Stohlman SA; Gallagher T; Lai MM
Virology; 1999 Nov; 264(2):398-409. PubMed ID: 10562501
[TBL] [Abstract][Full Text] [Related]
55. A combination of mutations in the S1 part of the spike glycoprotein gene of coronavirus MHV-A59 abolishes demyelination.
Fu L; Gonzales DM; Das Sarma J; Lavi E
J Neurovirol; 2004 Feb; 10(1):41-51. PubMed ID: 14982727
[TBL] [Abstract][Full Text] [Related]
56. Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease.
Yamamoto S; Yamashina K; Ishikawa M; Gotoh M; Yagishita S; Iwasa K; Maruyama K; Murakami-Murofushi K; Yoshikawa K
J Neuroinflammation; 2017 Jul; 14(1):142. PubMed ID: 28732510
[TBL] [Abstract][Full Text] [Related]
57. CD40L protects against mouse hepatitis virus-induced neuroinflammatory demyelination.
Saadi F; Chakravarty D; Kumar S; Kamble M; Saha B; Shindler KS; Das Sarma J
PLoS Pathog; 2021 Dec; 17(12):e1010059. PubMed ID: 34898656
[TBL] [Abstract][Full Text] [Related]
58. Myelin transcription factor 1 (Myt1) expression in demyelinated lesions of rodent and human CNS.
Vana AC; Lucchinetti CF; Le TQ; Armstrong RC
Glia; 2007 May; 55(7):687-97. PubMed ID: 17330875
[TBL] [Abstract][Full Text] [Related]
59. Contributions of CD8+ T cells and viral spread to demyelinating disease.
Marten NW; Stohlman SA; Atkinson RD; Hinton DR; Fleming JO; Bergmann CC
J Immunol; 2000 Apr; 164(8):4080-8. PubMed ID: 10754301
[TBL] [Abstract][Full Text] [Related]
60. In vivo and in vitro models of demyelinating disease: activation of the adenylate cyclase system influences JHM virus expression in explanted rat oligodendrocytes.
Beushausen S; Narindrasorasak S; Sanwal BD; Dales S
J Virol; 1987 Dec; 61(12):3795-803. PubMed ID: 2824815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
